MedTrace Logo

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

NCT05215197 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-12-27

No results posted yet for this study

Summary

Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.

Conditions

  • Hearing Loss, Sensorineural

Interventions

DRUG

intracochlear platelet rich fibrin administration

intracochlear platelet rich fibrin administration during routine cochlear implantation surgery

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2025-12-01
Completion
2025-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05215197 on ClinicalTrials.gov